Description
Jardiance® (empagliflozin) 10 mg Tablets – Bottle of 30 Tablets
Product Description:
Jardiance® is a prescription medication containing empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, used to improve glycemic control in adults with type 2 diabetes mellitus. Jardiance works by preventing the reabsorption of glucose in the kidneys, thereby increasing glucose excretion in urine and lowering blood sugar levels. It also provides cardiovascular benefits and has been shown to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease.
Product Features:
-
Active Ingredient: Empagliflozin
-
Strength: 10 mg per tablet
-
Dosage Form: Oral tablet
-
Quantity: Bottle of 30 tablets
-
Administration: Once daily, with or without food
Indications:
-
Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
-
Cardiovascular risk reduction: Proven to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease
-
Can be used alone or in combination with other antidiabetic medications, including insulin or metformin
Reviews
There are no reviews yet.